본문으로 건너뛰기
← 뒤로

The MCM/Lys-Cys nanodevices for the efficient gene delivery: An approach towardsMCP1gene manipulation using CRISPR technology.

1/5 보강
Colloids and surfaces. B, Biointerfaces 📖 저널 OA 4% 2024: 0/1 OA 2025: 0/26 OA 2026: 4/72 OA 2024~2026 2026 Vol.260() p. 115377
Retraction 확인
출처

Rahimi A, Rahimmanesh I, Abedpoor N, Boshtam M, Bidram E, Javanmard SH, Khanahmad H, Rafiee L, Bigham A, Rafienia M, Karbasi S, Shariati L

📝 환자 설명용 한 줄

Breast cancer continues to be the most common malignancy among women worldwide, requiring novel therapeutic approaches.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Rahimi A, Rahimmanesh I, et al. (2026). The MCM/Lys-Cys nanodevices for the efficient gene delivery: An approach towardsMCP1gene manipulation using CRISPR technology.. Colloids and surfaces. B, Biointerfaces, 260, 115377. https://doi.org/10.1016/j.colsurfb.2025.115377
MLA Rahimi A, et al.. "The MCM/Lys-Cys nanodevices for the efficient gene delivery: An approach towardsMCP1gene manipulation using CRISPR technology.." Colloids and surfaces. B, Biointerfaces, vol. 260, 2026, pp. 115377.
PMID 41443126 ↗

Abstract

Breast cancer continues to be the most common malignancy among women worldwide, requiring novel therapeutic approaches. This research investigates an innovative gene delivery strategy employing mesoporous silica nanoparticles (MCM-41) modified with lysine and cysteine (Lys-Cys) for the effective delivery of CRISPR-Cas9 plasmids aimed at the monocyte chemoattractant protein-1 (MCP-1/CCL2) gene. Bioinformatics analysis of the TCGA-BRCA dataset revealed substantial deregulation of CCL2 in breast cancer, underscoring its involvement in tumor growth and inflammation. The MCM/Lys-Cys nanocarrier demonstrated remarkable biocompatibility and effectively encapsulated a plasmid containing GFP, promoting superior cellular uptake in MDA-MB-231 breast cancer cells compared to conventional techniques. Functional experiments demonstrated that CRISPR/Cas9-mediated suppression of CCL2 markedly decreased cell proliferation, migration, and invasion, highlighting the promise of this targeted gene therapy strategy in breast cancer management. The findings indicate that the MCM/Lys-Cys nanosystem presents a viable non-viral approach for precise gene editing, potentially boosting therapeutic efforts against breast cancer by modulating inflammatory pathways.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반